Newsroom

Celdara Medical seeks outstanding scientists with an interest in translational research and biotechnology for a paid Fellowship ($15/hour – remote optional). Prior Fellows have jumpstarted their careers in Venture Capital, Management Consulting, Technology Transfer, R&D, Medical Writing, and Business Development.​    Program Description​  1-year experiential learning to gain real-world experience in biotechnology​  Develop executive skills including […]

Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Innovation Research (SBIR) Fast-Track grant to Celdara Medical. This award supports the ongoing development of CM-IAV1, a promising therapeutic antibody designed to treat high-priority influenzas that […]

Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Technology Transfer (STTR) grant to fund the ongoing development of therapeutic antibodies for the treatment of Hantavirus Cardiopulmonary Syndrome (HCPS). The funding will support the ongoing […]

Lebanon, NH: Celdara Medical, LLC announced today that participants in the inaugural DRIVEN Accelerator Hub Partner Program have collectively surpassed $100M in follow-on funding. Led by Celdara Medical and Simbex, and with seed funding from National Institute of General Medicine Sciences (NIGMS), the DRIVEN Accelerator Hub was established in 2018 […]

Celdara Medical and ARMI Partner to Accelerate Commercialization of Regional Biofabrication Technologies  Lebanon, NH: Celdara Medical today announced a partnership with the Advanced Regenerative Manufacturing Institute (ARMI) to support and advise ARMI’s newly-created BioFab Startup Lab and its portfolio companies.  The BioFab Startup Lab includes companies that are developing medical […]

Lebanon, NH: Celdara Medical is pleased to congratulate one of its Scientific Founders, Dr. Charles Sentman, on his recent selection as a 2022 National Academy of Inventors (NAI) Fellow. The NAI Fellows Program honors academic inventors who have demonstrated a prolific spirit of innovation in creating inventions with tangible impact […]

Lebanon, NH: Celdara Medical, LLC today announced Dr. Jonathan Heller as its first Entrepreneur in Residence (EIR). Celdara Medical is developing a diverse portfolio of preclinical therapeutic assets, platforms, and companies. Heller is primarily responsible for advancing one of Celdara’s lead therapeutic programs to spin-out or exit.    “Celdara’s pipeline […]

Celdara Medical Receives Funding to Develop Broad-Spectrum Antimicrobials for Chronic Lung Infection     Lebanon, NH: The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded Celdara Medical, LLC a Phase I Small Business Innovation Research (SBIR) grant for development of broad-spectrum antimicrobial peptides […]

Lebanon, NH: Celdara Medical, LLC announced today that the National Cancer Institute (NCI) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Innovation Research (SBIR) Fast-Track grant to fund company’s ongoing development of CM-CX1, a chimeric antigen receptor (CAR) T cell therapy for the treatment […]